Small Lymphocytic Leukemia Clinical Trials
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
C
B
Recruiting
- Diffuse Large B Cell Lymphoma
- +7 more
- BR101801 (Phase Ia)
- +2 more
- Seoul, Korea, Republic of
- +2 more
2021-11-19
Nov 19, 2021M
Recruiting
- Malignant Neoplasms Stated as Primary Lymphoid Haematopoietic
- +2 more
- Houston, TexasUniversity of Texas MD Anderson Cancer Center
2021-10-29
Oct 29, 2021U
Active, not recruiting
- Diffuse Large B Cell Lymphoma
- +3 more
- Acalabrutinib
- +4 more
- Miami, FloridaUniversity of Miami
2021-10-25
Oct 25, 2021M
Terminated
- Non-Hodgkin's B-cell Lymphoma
- +5 more
- MT-3724 Phase 1
- MT-3724 Phase 2
- Tucson, Arizona
- +40 more
2021-08-30
Aug 30, 2021D
Recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Leukemia
- Boston, Massachusetts
- +1 more
2021-03-04
Mar 4, 2021D
Terminated
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Leukemia
- Lenalidomide
- +2 more
- Boston, Massachusetts
- +1 more
2016-05-26
May 26, 2016M
Withdrawn
- Chronic B-cell Lymphocytic Leukemia
- Small Lymphocytic Leukemia
- (no location specified)
2016-02-29
Feb 29, 2016N
Unknown status
- Non-Hodgkin's Lymphoma
- +2 more
- AQ4N (Chemotherapy)
- New York, New YorkWeill Medical College of Cornell University/ New York Presbyteri
2007-05-04
May 4, 2007